LEADER 03439nam 2200661 a 450 001 9910779727603321 005 20230803021051.0 010 $a3-11-028707-2 024 7 $a10.1515/9783110287073 035 $a(CKB)2550000001096701 035 $a(EBL)1020432 035 $a(OCoLC)829461994 035 $a(SSID)ssj0000834322 035 $a(PQKBManifestationID)11460258 035 $a(PQKBTitleCode)TC0000834322 035 $a(PQKBWorkID)10936926 035 $a(PQKB)11628486 035 $a(MiAaPQ)EBC1020432 035 $a(DE-B1597)176592 035 $a(OCoLC)840442073 035 $a(DE-B1597)9783110287073 035 $a(Au-PeEL)EBL1020432 035 $a(CaPaEBR)ebr10661392 035 $a(CaONFJC)MIL503235 035 $a(EXLCZ)992550000001096701 100 $a20121031d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aTransfusion medicine and patient safety$b[electronic resource] /$fGiustina de Silvestro, Arianna Veronesi, Maria Vicarioto 210 $aBerlin $cDe Gruyter$dc2013 215 $a1 online resource (120 p.) 225 0 $aPatient Safety ;$v. 225 0$aPatient safety ;$vv. 7 300 $aDescription based upon print version of record. 311 $a3-11-028697-1 311 $a1-299-71984-8 320 $aIncludes bibliographical references and index. 327 $aBasics of transfusion medicine -- The transfusion process -- Automation and computerization of the transfusion process -- Biological validation of blood components -- Error in transfusion medicine. 330 $aBlood transfusion is considered a life-saving therapy since ancient times, but, at the same time, a high-risk procedure. Nowadays the common perception is that infection is the greatest risk, even if the blood has never been safer from this point of view. Currently, the residual risk of transfusion must be related mainly to immunological mechanisms underlying to AB0 and minor blood systems, to compatibility of blood transfused and to development of irregular antibodies in transfused patients. "Transfusion Medicine and Patient Safety" aims to provide the basic of immunohematology to readers and to analyze the transfusional process highlighting the most critical points, thus more exposed to errors. Screening on blood and blood components for infectious diseases along with the surveillance action on emerging viruses results in the drastic reduction of post-transfusion infection, together with the potential to further increase the level of security from infection through the inactivation of blood components.The text also describes the major diagnostic systems and organizational models that modern technology provides us with a correct immunohematological diagnosis and an appropriate trasfusional therapy. 410 0$aPatient Safety 606 $aBlood$xTransfusion 610 $aTransfusional Medicine, Patient Safety, Immunohaematology, Transfusion, Blood Donation. 615 0$aBlood$xTransfusion. 676 $a615.3/9 686 $aXL 1587$2rvk 700 $aDe Silvestro$b Giustina$01469034 701 $aVeronesi$b Arianna$01469035 701 $aVicarioto$b Maria$01469036 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910779727603321 996 $aTransfusion medicine and patient safety$93680434 997 $aUNINA